Talis Biomedical Corporation logo

Talis Biomedical Corporation (TLIS)

Delisted
1 Apr 2026
OTC PINK OTC PINK
$
2. 84
0
0%
$
5.18M Market Cap
- P/E Ratio
- Div Yield
1,677 Volume
0 Eps
$ 2.84
Previous Close
Investors:
Day Range
1.6 2.84
Year Range
1.04 2.84
Want to track TLIS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Talis Biomedical Corporation Investors

Name Quantity Cost Value Profit ($) Gain (%)
David Einhorn
David Einhorn Greenlight Capital Re Ltd.
149,052 $860,030 $860,030 - -